Independent
Tenure on this board
6.3 yrs
Meeting calendar
KOD · Annual meeting · Tuesday, June 2, 2026
Kodiak Sciences Inc
3 nominees · 3 ballot items.
Elect three directors; Advisory (non-binding) approval of named executive officer compensation (say-on-pay); Ratify appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm; Transact other business as may properly come before the meeting.
Market cap
$2.7B
1Y TSR
+589.2%
Board grade
B-
Record date
Apr 6, 2026
Filing
DEF 14A
Meeting concluded · Jun 2, 2026
Follow how the vote landed and what changed on Kodiak Sciences Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElect three Class II directors nominated by the Board (Charles A. Bancroft, Bassil I. Dahiyat, Ph.D., and Taiyin Yang, Ph.D.) to serve three-year terms.
- 2
Advisory Vote on Named Executive Officer Compensation (Say-on-Pay
ManagementBoard: FORNon-binding advisory vote to approve Kodiak’s named executive officer compensation as disclosed in the proxy statement.
More detail
This management proposal asks stockholders to cast a non-binding advisory vote to approve the overall compensation of the company’s named executive officers as disclosed in the proxy statement. Management seeks this advisory approval to obtain stockholder feedback on its executive pay program, which emphasizes pay-for-performance through a mix of base salary, performance-based cash bonuses, and long-term equity incentives including service-, performance- and price-based options and RSUs. The board recommends a vote FOR, citing alignment with stockholder interests, retention objectives, and use of independent compensation consultants and peer benchmarking. Context includes prior strong stockholder support (94% approval in 2025) and significant at-risk compensation through equity awards including the 2021 LTPIP with high stock-price hurdles; the vote is advisory and non-binding but the board will consider results when setting future compensation. The recommendation notes safeguards like double-trigger change-in-control protections, no excise tax gross-ups, and clawback policy, while risks include linkage to difficult-to-achieve stock price targets and significant realized value dependence on future share price performance.
- 3
Ratification of Appointment of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify the audit committee’s appointment of PricewaterhouseCoopers LLP as Kodiak’s independent registered public accounting firm for 2026.
Director elections
Nominees on the ballot3
Independent
Tenure on this board
8.1 yrs
Also a director at
Xencor Inc (XNCR)
Independent
Tenure on this board
6.6 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 31.8% | 19,919,186 | $759M |
| 2 | STATE STREET CORP | 3.6% | 2,250,920 | $86M |
| 3 | PRICE T ROWE ASSOCIATES INC /MD/ | 3.2% | 1,998,857 | $76M |
| 4 | BlackRock, Inc. | 3.0% | 1,871,438 | $71M |
| 5 | BRAIDWELL LP | 2.9% | 1,818,665 | $69M |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 2.7% | 1,717,076 | $65M |
| 7 | RTW INVESTMENTS, LP | 2.4% | 1,487,934 | $57M |
| 8 | GOLDMAN SACHS GROUP INC | 2.4% | 1,481,318 | $56M |
| 9 | TCG Crossover Management, LLC | 2.3% | 1,445,538 | $55M |
| 10 | Boxer Capital Management, LLC | 2.2% | 1,361,000 | $52M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Kodiak Sciences Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Prestige Consumer Healthcare IncPBH
Annual meeting·Aug 4, 2026·$2.4B
Haemonetics CorpHAE
Annual meeting·Jul 24, 2026·$3.5B
Organon & CoOGN
Special meeting·Jul 23, 2026·$3.6B
Trulieve Cannabis CorpTRLV
Special meeting·Aug 5, 2026·$1.7B
Anaptysbio IncANAB
Annual meeting·Aug 11, 2026·$1.7B
Doximity IncDOCS
Annual meeting·Aug 27, 2026·$3.9B
Reference
Frequently asked questions
- When is the Kodiak Sciences Inc 2026 annual meeting?
- Kodiak Sciences Inc (KOD) holds its 2026 annual shareholder meeting on Tuesday, June 2, 2026.
- What is the record date for the Kodiak Sciences Inc 2026 meeting?
- The record date for the Kodiak Sciences Inc 2026 meeting is Monday, April 6, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Kodiak Sciences Inc's 2026 meeting?
- The board is presenting 3 director nominees at the Kodiak Sciences Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Kodiak Sciences Inc 2026 meeting?
- Shareholders will vote on 3 proposals at the Kodiak Sciences Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.